- 
                                    - 
                                            Overview
                                            - 
                                                    
                                                    Please contact us at for specific academic pricing. BackgroundIndomethacin, an anti-inflammatory agent, inhibits Cox-1 and Cox-2 (cyclooxygenases) with selectivity for Cox-1 (IC50 of 230 nM) over Cox-2 (IC50 of 630 nM). Additionally, Indomethacin displays adipogenic actions via binding and activation of PPARγ (peroxisome proliferator-activated receptor γ), a ligand-activated transcription factor known to play an important role in adipogenesis. Other studies show Indomethacin to stabilize cholesterol-dependent nanoclusters and enhance phase separation in biological membranes, which could consequentially effect plasma membrane assembled cell signaling cascades. Indomethacin is an activator of PPAR α. 
 
- 
                                                    
                                                    
- Properties
 
- 
                                            Overview
                                            
 
                                            
                    
                        
                        
                                     
                                                                                                         
                                                                                                         
                                                                                                         
                    